Other examples include PTEN mutation in SW1783 cells associated with resistance to the NAMPT (nicotinamide phosphoribosyltransferase) inhibitor daporinad in EGFR amplified low-grade glioma cell lines (Figure 1F). This evidence concerns the gene EGFR and central nervous system cancer.